Accelerated access to novel cancer therapies at Moores Cancer Center

The tax incentives in the One Big Beautiful Bill Act passed by Congress and signed into law by President Trump last year are a prime example of the public policies reinforcing the U.S. position as the global leader in medtech innovation. 

 WASHINGTON—AdvaMed, the Medtech Association, the largest trade association representing medtech innovators, thanked President Trump and Congress for enacting the Small Business Innovation and Economic Security Act (S. 3971). Signed into law, the legislation reauthorizes the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

WASHINGTON—AdvaMed, the Medtech Association, today applauded House of Representatives passage of S. 3971, the Small Business Innovation and Economic Security Act, legislation reauthorizing the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. House passage follows Senate passage earlier this month, bringing the restoration of these initiatives one step closer to completion.  

WASHINGTON—AdvaMed, the Medtech Association, today welcomed Senate approval of legislation reauthorizing the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and urged the House of Representatives to act swiftly on passage.

Read how shifting to a capability-driven procurement model enables medtech organizations to better align sourcing decisions with business strategy, and strengthen cross-functional collaboration.

WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, made the following comment on the collaboration between Revival Healthcare Capital and Olympus Corporation to co-found Swan EndoSurgical, Inc. to develop a robotics platform to provide earlier, safer, and more effective treatment of lesions or tumors in the gastrointestinal tract relative to current therapeutic options. 

WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) and U.S. Reps. Kevin Hern (R-Okla.) and Mike Thompson (D-Calif.). The bill provides for Medicare and Medicaid coverage of evidence-based software applications used to prevent, manage, or treat medical conditions.

EPAM recently published a case study highlighting the rise of composable commerce solutions to enable B2B processes in the healthcare industry. This piece focuses on the experience of diagnostics company, Cepheid – a part of Danaher Corporation.